Results of Landmark Trials (ENGAGE-AF) Investigating the Safety, Efficacy, and Clinical Outcomes Associated with Factor Xa Inhibition for Stroke Prevention in AF: Focus on Subset Analysis of Patients with High Risk Features and Vulnerabilities